Virtual Reality Effect in Geriatric Individuals

Depression Clinical Trial

Official title:

Effect of Virtual Reality Application on Pain, Functional Independence and Depression in Geriatric Individuals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04268589
• Other study ID #: OGUU
• Status: Completed
• Phase: N/A
• Start date: May 1, 2019
• Est. completion date: June 30, 2019

Study information

• Verified date: February 2020
• Source: Selcuk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to determine the effect of a virtual reality experience on pain, depression and functional adequacy in geriatric individuals living in a nursing home.

A virtual reality video with dance moves has been applied to the experimental group participants. Each video takes 3 minutes, and the elderly person has been put into practice at least 30 minutes after having breakfast in 3-minute periods and at least 30 minutes after dinner. In the morning and evening, 15 minutes, 2 times a day, a total of 9 days were applied for 3 weeks. The application lasted a total of 3 weeks. Scales were applied 1 week after the virtual reality application was completed and 1 month after the experimental group. The scales were filled in the control group at the same time.

Description:

It is recommended that the future studies be conducted with larger samples on pain, depression, life quality and functionality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: June 30, 2019
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 65 Years to 75 Years

Eligibility

Inclusion Criteria:

• Suffering from musculoskeletal pain in the last 3 years,

• Being energetic (Being independent in the daily life activities),

• Being able to stand up without help before 30 seconds and walk at least six meters without help,

• Individuals with blood sugar ranging between 90-200 mg/dl prior to the application,

• Individuals with blood pressure ranging between 130-70 mm/Hg prior to the application,

• Not having neurological and psychiatric diseases,

• No history of fall,

• Being literate,

• Not being visually-hearing impaired,

• Being able to communicate verbally.

Exclusion Criteria:

• Pependent patients

• Patients with psychiatric illness

• Patients with joint pain disease diagnosis

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Pain

Intervention

Other:
• virtual reality game
routine

Locations

Country	Name	City	State
Turkey	Osmangazi University	Eskisehir

Sponsors (1)

Lead Sponsor	Collaborator
Selcuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The visual analog scale (VAS)	This form includes numbers and is used in the assessment of pain severity. Patients mark their pain severity on a 10 cm ruler which is written no pain on one side and the most severe pain as possible on the other side. It has been stated that VAS is more sensitive and reliable in the measurement of pain severity than one sized scales	nine days
Primary	Geriatric Depression Scale	The scale was developed by Yesavage with the aim of assessing the depression symptoms of old persons and consists of 15 questions in total. In the assessment, 1 point is given to each "no" answer in the positive questions and to each "yes" answer in the negative questions. A score of 6 and higher in the scale is accepted as meaningful for the diagnosis of depression. Reliability and validity tests were performed in our country and Chronbach alpha internal consistency coefficient was found to be 0.92	nine days